Innovations in Cell Culture: Cells, Media and Therapies

Sponsored by

Corning Life Sciences


Wednesday September 26, 2012 from 4:00 PM to 6:00 PM MDT

Add to my calendar 


Rocky Mountain Innosphere
320 E Vine Drive
Fort Collins, CO 80524

Driving Directions 


Emily Wilson
Rocky Mountain Innosphere

A New Era of Biomedicine
Cell culture has been the workhorse of biotechnology with large scale biomanufacturing of therapeutic antibodies, recombinant proteins and vaccines. Now, cells are themselves becoming medicine in the emerging field of regenerative medicine and cellular therapy. Learn how this new era of biomedicine is developing and take a guided lab tour of two companies who are at the forefront of this exciting industry.

Event Agenda:
Welcome & Overview of Corning
Todd Sciortino
BioProcess & Advanced Life Science Specialist, Corning
Life Sciences


  • Are We There Yet?
    The Status of Stem Cell Therapy

    Shawn Rossi
    , Principal Consultant, Rossi & Associates

Lab Tours

  • ART - Advanced Regenerative Therapies
    T.K. Pope, BS, MS.,
    Cell Biologist & Technical Liaison
  • InVitria, A Division of Ventria Bioscience
    Steve Pettit, Ph.D.,
    Director of Cell Culture Development

A reception will immediately follow the presentation.

Event Partners
Event Partner Organizations: ART, InVitria, CSU Ventures, CBSA, The Cell Culture Dish
Event Hosts
Eventhosts: Rocky Mountain Innosphere, NOCOBIO

Presenter and Tour Guide Bios

Todd Sciortino Todd Sciortino
BioProcess & Advanced Life Science Specialist
Corning Life Sciences

Todd has helped scientific teams get closer to their goals within Cell Therapy, Recombinant Protein Production and Diagnostic Laboratories. He has been part of the cell culture industry with BioTransplant, Mediatech, and most recently Corning Life Sciences.  With Corning, Todd is advocating new vessels for cell manufacturing and customizable options for bioprocessing. Todd is a graduate in Microbiology from the University of New Hampshire.
  Steve Pettit, Ph.D.
Director of Cell Culture Development
InVitria, A Division of Ventria Bioscience

Steve develops animal component free cell culture supplements that improve performance and consistency for a variety of mammalian cell lines. Steve and collaborators won a $1.5 million NIH award to develop an animal component free cell culture media for vaccine manufacturing. Prior to InVitria, Steve worked with University of North Carolina School of Medicine where he authored numerous papers.  Steve received his B.S. in Chemical Biology from Rhodes College and his Ph.D (Biochemistry) from the University of Alabama, Birmingham.
Shawn Rossi
Principal Consultant
Rossi & Associates

Mr. Rossi is a strategy consultant in the cell therapy and regenerative medicine industry. He served as Global Sales Manager, Cell Therapy/Cell Processing at Terumo BCT where he led commercialization of the Quantum Cell Expansion System, a stem cell product manufacturing technology. He was previously Director of Business Development at BioE, Inc., an adult source stem cell company. He is a member of the Alliance for Regenerative Medicine (ARM), Alliance for Advanced Therapies (AAT), International Society of Cell Therapy (ISCT) and the International Society of Stem Cell Research (ISSCR). Mr. Rossi received his B.A. from the University of Pennsylvania.
T.K. Pope, B.S., M.S.
Cell Biologist & Technical Liaison
ART - Advanced Regenerative Therapies

T.K. isolates and cultures bone marrow-derived mesenchymal stem cells for use in veterinary regenerative medicine by ART's customers. ART's methods have been used in thousands of successful regenerative medicine procedures. T.K. is a technical expert who helps educate veterinarians on marrow aspiration techniques and applications for stem cells in orthopedic regenerative medicine. Prior to ART, T.K. worked in the biopharmaceutical industry to develop recombinant human hemoglobin and enzymatic inhibitors associated with cardiomyopathies. T.K. earned a B.S. in Biological Sciences and a M.S. in Physiology from Colorado State University.